These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 34016601)
1. The SAgA of Antigen-Specific Immunotherapy for Type 1 Diabetes. Mallone R; You S Diabetes; 2021 Jun; 70(6):1247-1249. PubMed ID: 34016601 [No Abstract] [Full Text] [Related]
2. New prospects for immunotherapy at diagnosis of type 1 diabetes. Pozzilli P; Leslie RD Diabetes Metab Res Rev; 2009 May; 25(4):299-301. PubMed ID: 19405079 [TBL] [Abstract][Full Text] [Related]
3. Tackling type 1 diabetes: new immune-modulating drugs attack the root cause. Shekhar C Chem Biol; 2007 Dec; 14(12):1305-6. PubMed ID: 18096495 [No Abstract] [Full Text] [Related]
4. Biomarkers for antigen immunotherapy in allergy and type 1 diabetes. Odegard JM; Nepom GT; Wambre E Clin Immunol; 2015 Nov; 161(1):44-50. PubMed ID: 26122171 [TBL] [Abstract][Full Text] [Related]
5. Antigen-specific immunotherapy: oral tolerance and subcutaneous immunization in the treatment of insulin-dependent diabetes. Muir A; Schatz D; Maclaren N Diabetes Metab Rev; 1993 Dec; 9(4):279-87. PubMed ID: 7924825 [No Abstract] [Full Text] [Related]
6. Immunotherapy in type 1 diabetes. Pozzilli P Diabet Med; 1988 Nov; 5(8):734-8. PubMed ID: 2975564 [No Abstract] [Full Text] [Related]
7. A Question of Tolerance-Antigen-Specific Immunotherapy for Type 1 Diabetes. Loaiza Naranjo JD; Bergot AS; Buckle I; Hamilton-Williams EE Curr Diab Rep; 2020 Nov; 20(12):70. PubMed ID: 33169191 [TBL] [Abstract][Full Text] [Related]
8. Innovative immune-based therapeutic approaches for the treatment of type 1 diabetes mellitus. Eldor R; Cohen IR; Raz I Int Rev Immunol; 2005; 24(5-6):327-39. PubMed ID: 16318985 [TBL] [Abstract][Full Text] [Related]
10. B cell-targeted immunotherapy for type 1 diabetes: What can make it work? Hamad AR; Ahmed R; Donner T; Fousteri G Discov Med; 2016 Mar; 21(115):213-9. PubMed ID: 27115172 [TBL] [Abstract][Full Text] [Related]
11. Antigen-specific immunotherapy and influenza vaccination in type 1 diabetes: timing is everything. Yeo L; Peakman M Diabetologia; 2017 Jul; 60(7):1180-1184. PubMed ID: 28540458 [No Abstract] [Full Text] [Related]
12. Type I insulin dependent diabetes: an autoimmune disease that can be arrested or prevented with immunotherapy? Winter WE; Maclaren NK Adv Pediatr; 1985; 32():159-75. PubMed ID: 3909773 [No Abstract] [Full Text] [Related]
13. [Immunointervention in type 1 diabetes mellitus]. Vialettes B Diabete Metab; 1992; 18(1):3-10; discussion 11-3. PubMed ID: 1563533 [No Abstract] [Full Text] [Related]
14. [Principles of immunotherapy in insulin-dependent diabetes mellitus]. Bretzel RG Wien Klin Wochenschr; 1988 Jun; 100(13):435-42. PubMed ID: 3043913 [TBL] [Abstract][Full Text] [Related]
15. Editorial Comment on type 1 diabetes and antigen-specific immunotherapy. Lernmark Å; Larsson HE J Intern Med; 2011 Aug; 270(2):132-5. PubMed ID: 21668820 [No Abstract] [Full Text] [Related]
16. Immunotherapy in type I diabetes. Approaches to prevention and treatment. Colman PG; Eisenbarth GS Postgrad Med; 1987 May; 81(6):146-55. PubMed ID: 3554198 [TBL] [Abstract][Full Text] [Related]
18. Antigen-Specific Peptide Immunotherapy for Type 1 Diabetes: Proof of Safety, Hope for Efficacy. Coppieters K; von Herrath M Cell Metab; 2017 Oct; 26(4):595-597. PubMed ID: 28978425 [TBL] [Abstract][Full Text] [Related]
19. Pathophysiology of immune-mediated (type 1) diabetes mellitus: potential for immunotherapy. Abel M; Krokowski M BioDrugs; 2001; 15(5):291-301. PubMed ID: 11437693 [TBL] [Abstract][Full Text] [Related]